Rare diseases
Investigational molecules
Locations
Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
LatviaStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
LatviaEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
LatviaPhase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
LatviaEfficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial
LatviaRandomized Study of Intravitreal mk-8748 Compared with Aflibercept in Patients with Neovascular Age‑Related Macular Degeneration
LatviaGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
LatviaA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
LatviaLong-Term Study of Imeroprubart in Adults With Graves' Disease
LatviaA study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.
LatviaComparing Sotorasib and Pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
LatviaA study to evaluate the effectiveness and safety of REGN13335 in adults with pulmonary arterial hypertension
LatviaTell us about your condition – we search every trial in Europe and connect you with the right site.
